Global Meropenem Powder Injection Market Growth 2024-2030

Publication ID:

LPI11240037

Publication Date:

November 15, 2024

Pages:

113

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Meropenem Powder for Injection refers to a sterile powder form of the antibiotic meropenem that is intended for reconstitution with a suitable solvent(usually sterile water for injection)prior to intravenous administration.Meropenem is a synthetic broad-spectrum carbapenem antibiotic.It exerts a powerful antibacterial effect by inhibiting the synthesis of bacterial cell walls and has good antibacterial activity against Gram-positive bacteria,Gram-negative bacteria and anaerobic bacteria.It is often used to treat a variety of severe bacterial infections,such as pneumonia,sepsis,abdominal infections,meningitis,etc.
The global Meropenem Powder Injection market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
The 鈥淢eropenem Powder Injection Industry Forecast鈥� looks at past sales and reviews total world Meropenem Powder Injection sales in 2023, providing a comprehensive analysis by region and market sector of projected Meropenem Powder Injection sales for 2024 through 2030. With Meropenem Powder Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Meropenem Powder Injection industry.
This Insight Report provides a comprehensive analysis of the global Meropenem Powder Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Meropenem Powder Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Meropenem Powder Injection market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Meropenem Powder Injection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Meropenem Powder Injection.
United States market for Meropenem Powder Injection is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Meropenem Powder Injection is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Meropenem Powder Injection is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Meropenem Powder Injection players cover Intelicure Lifesciences, Pfizer, Sumitomo Pharma, CSPC Pharmaceutical Group, Joincare, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Meropenem Powder Injection market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
0.25g per Vial
0.50g per Vial
1.0g per Vial
Segmentation by Application:
Urinary Tract Infection
Meningitis
Septicemia
Skin and Soft Tissue Infections锛圫STI锛�
Gynecological Infections
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Intelicure Lifesciences
Pfizer
Sumitomo Pharma
CSPC Pharmaceutical Group
Joincare
Haikou Pharmaceutical Factory
Luoxin Pharna
Hisun
United Laboratories
PKU HealthCare
Chongqing Shenghuaxi Pharma
Shanghai Pharma
Key Questions Addressed in this Report
What is the 10-year outlook for the global Meropenem Powder Injection market?
What factors are driving Meropenem Powder Injection market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Meropenem Powder Injection market opportunities vary by end market size?
How does Meropenem Powder Injection break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Meropenem Powder Injection Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Meropenem Powder Injection by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Meropenem Powder Injection by Country/Region, 2019, 2023 & 2030
2.2 Meropenem Powder Injection Segment by Type
2.2.1 0.25g per Vial
2.2.2 0.50g per Vial
2.2.3 1.0g per Vial
2.3 Meropenem Powder Injection Sales by Type
2.3.1 Global Meropenem Powder Injection Sales Market Share by Type (2019-2024)
2.3.2 Global Meropenem Powder Injection Revenue and Market Share by Type (2019-2024)
2.3.3 Global Meropenem Powder Injection Sale Price by Type (2019-2024)
2.4 Meropenem Powder Injection Segment by Application
2.4.1 Urinary Tract Infection
2.4.2 Meningitis
2.4.3 Septicemia
2.4.4 Skin and Soft Tissue Infections锛圫STI锛�
2.4.5 Gynecological Infections
2.4.6 Other
2.5 Meropenem Powder Injection Sales by Application
2.5.1 Global Meropenem Powder Injection Sale Market Share by Application (2019-2024)
2.5.2 Global Meropenem Powder Injection Revenue and Market Share by Application (2019-2024)
2.5.3 Global Meropenem Powder Injection Sale Price by Application (2019-2024)
3 Global by Company
3.1 Global Meropenem Powder Injection Breakdown Data by Company
3.1.1 Global Meropenem Powder Injection Annual Sales by Company (2019-2024)
3.1.2 Global Meropenem Powder Injection Sales Market Share by Company (2019-2024)
3.2 Global Meropenem Powder Injection Annual Revenue by Company (2019-2024)
3.2.1 Global Meropenem Powder Injection Revenue by Company (2019-2024)
3.2.2 Global Meropenem Powder Injection Revenue Market Share by Company (2019-2024)
3.3 Global Meropenem Powder Injection Sale Price by Company
3.4 Key Manufacturers Meropenem Powder Injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Meropenem Powder Injection Product Location Distribution
3.4.2 Players Meropenem Powder Injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Meropenem Powder Injection by Geographic Region
4.1 World Historic Meropenem Powder Injection Market Size by Geographic Region (2019-2024)
4.1.1 Global Meropenem Powder Injection Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Meropenem Powder Injection Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Meropenem Powder Injection Market Size by Country/Region (2019-2024)
4.2.1 Global Meropenem Powder Injection Annual Sales by Country/Region (2019-2024)
4.2.2 Global Meropenem Powder Injection Annual Revenue by Country/Region (2019-2024)
4.3 Americas Meropenem Powder Injection Sales Growth
4.4 APAC Meropenem Powder Injection Sales Growth
4.5 Europe Meropenem Powder Injection Sales Growth
4.6 Middle East & Africa Meropenem Powder Injection Sales Growth
5 Americas
5.1 Americas Meropenem Powder Injection Sales by Country
5.1.1 Americas Meropenem Powder Injection Sales by Country (2019-2024)
5.1.2 Americas Meropenem Powder Injection Revenue by Country (2019-2024)
5.2 Americas Meropenem Powder Injection Sales by Type (2019-2024)
5.3 Americas Meropenem Powder Injection Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Meropenem Powder Injection Sales by Region
6.1.1 APAC Meropenem Powder Injection Sales by Region (2019-2024)
6.1.2 APAC Meropenem Powder Injection Revenue by Region (2019-2024)
6.2 APAC Meropenem Powder Injection Sales by Type (2019-2024)
6.3 APAC Meropenem Powder Injection Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Meropenem Powder Injection by Country
7.1.1 Europe Meropenem Powder Injection Sales by Country (2019-2024)
7.1.2 Europe Meropenem Powder Injection Revenue by Country (2019-2024)
7.2 Europe Meropenem Powder Injection Sales by Type (2019-2024)
7.3 Europe Meropenem Powder Injection Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Meropenem Powder Injection by Country
8.1.1 Middle East & Africa Meropenem Powder Injection Sales by Country (2019-2024)
8.1.2 Middle East & Africa Meropenem Powder Injection Revenue by Country (2019-2024)
8.2 Middle East & Africa Meropenem Powder Injection Sales by Type (2019-2024)
8.3 Middle East & Africa Meropenem Powder Injection Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Meropenem Powder Injection
10.3 Manufacturing Process Analysis of Meropenem Powder Injection
10.4 Industry Chain Structure of Meropenem Powder Injection
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Meropenem Powder Injection Distributors
11.3 Meropenem Powder Injection Customer
12 World Forecast Review for Meropenem Powder Injection by Geographic Region
12.1 Global Meropenem Powder Injection Market Size Forecast by Region
12.1.1 Global Meropenem Powder Injection Forecast by Region (2025-2030)
12.1.2 Global Meropenem Powder Injection Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Meropenem Powder Injection Forecast by Type (2025-2030)
12.7 Global Meropenem Powder Injection Forecast by Application (2025-2030)
13 Key Players Analysis
13.1 Intelicure Lifesciences
13.1.1 Intelicure Lifesciences Company Information
13.1.2 Intelicure Lifesciences Meropenem Powder Injection Product Portfolios and Specifications
13.1.3 Intelicure Lifesciences Meropenem Powder Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Intelicure Lifesciences Main Business Overview
13.1.5 Intelicure Lifesciences Latest Developments
13.2 Pfizer
13.2.1 Pfizer Company Information
13.2.2 Pfizer Meropenem Powder Injection Product Portfolios and Specifications
13.2.3 Pfizer Meropenem Powder Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Pfizer Main Business Overview
13.2.5 Pfizer Latest Developments
13.3 Sumitomo Pharma
13.3.1 Sumitomo Pharma Company Information
13.3.2 Sumitomo Pharma Meropenem Powder Injection Product Portfolios and Specifications
13.3.3 Sumitomo Pharma Meropenem Powder Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Sumitomo Pharma Main Business Overview
13.3.5 Sumitomo Pharma Latest Developments
13.4 CSPC Pharmaceutical Group
13.4.1 CSPC Pharmaceutical Group Company Information
13.4.2 CSPC Pharmaceutical Group Meropenem Powder Injection Product Portfolios and Specifications
13.4.3 CSPC Pharmaceutical Group Meropenem Powder Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 CSPC Pharmaceutical Group Main Business Overview
13.4.5 CSPC Pharmaceutical Group Latest Developments
13.5 Joincare
13.5.1 Joincare Company Information
13.5.2 Joincare Meropenem Powder Injection Product Portfolios and Specifications
13.5.3 Joincare Meropenem Powder Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Joincare Main Business Overview
13.5.5 Joincare Latest Developments
13.6 Haikou Pharmaceutical Factory
13.6.1 Haikou Pharmaceutical Factory Company Information
13.6.2 Haikou Pharmaceutical Factory Meropenem Powder Injection Product Portfolios and Specifications
13.6.3 Haikou Pharmaceutical Factory Meropenem Powder Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Haikou Pharmaceutical Factory Main Business Overview
13.6.5 Haikou Pharmaceutical Factory Latest Developments
13.7 Luoxin Pharna
13.7.1 Luoxin Pharna Company Information
13.7.2 Luoxin Pharna Meropenem Powder Injection Product Portfolios and Specifications
13.7.3 Luoxin Pharna Meropenem Powder Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Luoxin Pharna Main Business Overview
13.7.5 Luoxin Pharna Latest Developments
13.8 Hisun
13.8.1 Hisun Company Information
13.8.2 Hisun Meropenem Powder Injection Product Portfolios and Specifications
13.8.3 Hisun Meropenem Powder Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Hisun Main Business Overview
13.8.5 Hisun Latest Developments
13.9 United Laboratories
13.9.1 United Laboratories Company Information
13.9.2 United Laboratories Meropenem Powder Injection Product Portfolios and Specifications
13.9.3 United Laboratories Meropenem Powder Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 United Laboratories Main Business Overview
13.9.5 United Laboratories Latest Developments
13.10 PKU HealthCare
13.10.1 PKU HealthCare Company Information
13.10.2 PKU HealthCare Meropenem Powder Injection Product Portfolios and Specifications
13.10.3 PKU HealthCare Meropenem Powder Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 PKU HealthCare Main Business Overview
13.10.5 PKU HealthCare Latest Developments
13.11 Chongqing Shenghuaxi Pharma
13.11.1 Chongqing Shenghuaxi Pharma Company Information
13.11.2 Chongqing Shenghuaxi Pharma Meropenem Powder Injection Product Portfolios and Specifications
13.11.3 Chongqing Shenghuaxi Pharma Meropenem Powder Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Chongqing Shenghuaxi Pharma Main Business Overview
13.11.5 Chongqing Shenghuaxi Pharma Latest Developments
13.12 Shanghai Pharma
13.12.1 Shanghai Pharma Company Information
13.12.2 Shanghai Pharma Meropenem Powder Injection Product Portfolios and Specifications
13.12.3 Shanghai Pharma Meropenem Powder Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Shanghai Pharma Main Business Overview
13.12.5 Shanghai Pharma Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂